2023-03-062023-03-062003Baykara, M. vd. (2003). “The effect of anterior chamber maintainer on anterior chamber contamination”. European Journal of Ophthalmology, 13(9-10), 770-772.1120-6721https://doi.org/10.1177/1120672103013009-1006https://journals.sagepub.com/doi/10.1177/1120672103013009-1006http://hdl.handle.net/11452/31357PURPOSE. To evaluate the effect of anterior chamber continuous infusion maintainer system on the contamination of anterior chamber in phacoemulsification surgery. METHODS. Clear corneal phacoemulsification surgery was performed in 132 eyes of 132 randomly selected patients with cataract who were divided into two groups of 66 eyes according to the use of an anterior chamber maintainer (ACM) system. The fluid specimens were taken from anterior chamber in the beginning and at the end of the surgery. They were transferred under anaerobic conditions and investigated by culturing onto blood agar and thiogluconate broth media. Differences between the two groups with respect to contamination of the specimens were investigated. RESULTS. The mean age of the group undergoing surgery without a maintainer system (Group A) was 63 +/- 10 years (min = 41, max = 80) versus 59 +/- 10 years (min = 33, max = 80) in the other group (Group B) in which the maintainer was used during surgery. In the postoperative specimen, Micrococcus species were isolated from one eye (1.5%) in Group A and S. pyogenes in one eye (1.5%) from Group B. Mean follow-up interval was 12 +/- 6 (min = 4, max 28) months. CONCLUSIONS. The use of ACM system in clear corneal phacoemulsification surgery carries no additional risks as far as contamination is concerned.eninfo:eu-repo/semantics/closedAccessOphthalmologyPhacoemulsificationAnterior chamber contaminationAnterior chamber maintainerCataract-surgerySurgical techniqueArticle0001874284000062-s2.0-1042290360770772139-1014700097OphthalmologyEndophthalmitis; Anti-Bacterial Agents; CefuroximeAdultAgedAnterior chamber maintainerAnterior eye chamber diseaseArticleClinical trialContaminationContinuous infusionControlled clinical trialControlled studyCulture mediumFemaleFollow upHumanMajor clinical studyMaleMicrococcusPhacoemulsificationPriority journalAgarRandomized controlled trialSurgical technique